Zobrazeno 1 - 10
of 41
pro vyhledávání: '"Chuan Chou Tu"'
Autor:
Chuan-Chou Tu, Shih-Yen Weng, Nan-Chen Hsieh, Wen-Chang Cheng, Javad Alizargar, Ko-Shih Chang
Publikováno v:
Journal of Multidisciplinary Healthcare. 16:411-418
Autor:
Rathinasamy Baskaran, Hsi Hsien Hsu, Wei Wen Kuo, Nien Hung Lee, Chuan Chou Tu, Ming Cheng Chen, Tsung Jung Ho, Yueh Min Lin, Vijaya Padma Viswanadha, Chih Yang Huang
Publikováno v:
Journal of Cellular Physiology. 234:11822-11834
Cancer stem cells (CSCs) exist in colon cancer and exhibit characteristics of stem cells which are due to lineages of tissues where they arise. Epithelial to mesenchymal transition (EMT)-undergoing cancer cells display CSC properties and therapeutic
Autor:
Chuan-Chou Tu, Ming-Cheng Chen, Chih Yang Huang, Hsi-Hsien Hsu, Po-Hsiang Liao, Yu-Chun Chang, Yu-Lan Yeh, Vijaya Padma Viswanadha, Wei Wen Kuo, Yi-Sheng Liu
Publikováno v:
Cancers
Hepatocellular carcinoma (HCC) is a common fatal type of malignant tumor that has highly metastatic and recurrent properties. Fisetin is a natural flavonoid found in various vegetables and fruits which exhibits anti-cancer and anti-inflammatory prope
Autor:
Yi-Sheng Liu, Yu-Chun Chang, Wei-Wen Kuo, Ming-Cheng Chen, Hsi-Hsien Hsu, Chuan-Chou Tu, Yu-Lan Yeh, Vijaya Padma Viswanadha, Po-Hsiang Liao, Chih-Yang Huang
Publikováno v:
Cancers, Vol 12, Iss 3241, p 3241 (2020)
It has been reported that two sets of blot figures in Figure 3A,C looked identical in the original published paper [...]
Autor:
Chuan Chou Tu, Jaw Ji Yang, Wei Wen Kuo, Yueh Min Lin, Hsi Hsien Hsu, Vijaya Padma Viswanadha, Chih Yang Huang, Ming Cheng Chen, Ke Ding, Yan Shen Tseng, Chien Yao Fu
Publikováno v:
Cell Biochemistry and Function. 36:176-182
ZAK is a novel mixed lineage kinase-like protein that contains a leucine-zipper and a sterile-alpha motif as a protein-protein interaction domain, and it is located in the cytoplasm. There are 2 alternatively spliced forms of ZAK: ZAKα and ZAKβ. Pr
Autor:
Yueh Min Lin, Ming Cheng Chen, V. Vijaya Padma, Chuan Chou Tu, Cecilia Hsuan Day, Bharath Kumar Velmurugan, Long Bin Jeng, Hsi Hsien Hsu, Tsung Jung Ho, Chih Yang Huang
Publikováno v:
Journal of Cellular Physiology. 233:7134-7142
Irinotecan (CPT11) and Oxaliplatin have been used in combination with fluorouracil and leucovorin for treating colorectal cancer. However, the efficacy of these drugs is reduced due to various side effects and drug resistance. Fisetin, a hydroxyflavo
Autor:
Chuan Chou Tu, Ming Cheng Chen, Chih Yang Huang, Cecilia Hsuan Day, Yueh Min Lin, Wei Wen Kuo, V. Vijaya Padma, Rathinasamy Baskaran, Hsi Hsien Hsu, Yi Jiun Lin
Publikováno v:
Journal of Cellular Physiology. 233:5458-5467
Oxaliplatin (OXA), is a third generation platinum drug used as first-line chemotherapy in colorectal cancer (CRC). Cancer cells acquires resistance to anti-cancer drug and develops resistance. ATP-binding cassette (ABC) drug transporter ABCG2, one of
Autor:
Jaw Ji Yang, Yan Shen Tseng, Yueh Min Lin, Vijaya Padma Viswanadha, Wei Wen Kuo, Chien Yao Fu, Hsi Hsien Hsu, Chuan Chou Tu, Ming Cheng Chen, Chih Yang Huang
Publikováno v:
Environmental Toxicology. 33:191-197
Human osteosarcoma (OS) is a malignant cancer of the bone. It exhibits a characteristic malignant osteoblastic transformation and produces a diseased osteoid. A previous study demonstrated that doxorubicin (DOX) chemotherapy decreases human OS cell p
Autor:
Viswanadha Vijaya Padma, Ming Cheng Chen, Shin Yi Li, Yueh Min Lin, Chih Yang Huang, Cecilia Hsuan Day, Hsi Hsien Hsu, Hui Nung Shih, Chuan Chou Tu, Wei Wen Kuo
Publikováno v:
World Journal of Gastroenterology
AIM To identify potential anti-cancer constituents in natural extracts that inhibit cancer cell growth and migration. METHODS Our experiments used high dose thymoquinone (TQ) as an inhibitor to arrest LoVo (a human colon adenocarcinoma cell line) can
FOXC1 Regulation of miR-31-5p Confers Oxaliplatin Resistance by Targeting LATS2 in Colorectal Cancer
Autor:
Hsi Hsien Hsu, Sue Fei Cheng, Po Hsiang Liao, Hui Nung Shih, Chuan Chou Tu, Ching Kuo Yang, Vijaya Padma Viswanadha, Wei Wen Kuo, Ming Cheng Chen, Chih Yang Huang
Publikováno v:
Cancers, Vol 11, Iss 10, p 1576 (2019)
Cancers; Volume 11; Issue 10; Pages: 1576
Cancers
Cancers; Volume 11; Issue 10; Pages: 1576
Cancers
Colorectal cancer (CRC) is the second leading cause of cancer-related illness worldwide and one of the most common malignancies. Therefore, colorectal cancer research and cases have gained increasing attention. Oxaliplatin (OXA) is currently used in